4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-035472
Chief Scientific Officer sold 1,094 shares at $11.83 ($12,942)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Beskrovnaya Oxana Chief Scientific Officer | 2025-03-05 | Sale 10b5-1 | −1,094 | $11.83 | $12,942 | 197,993 | D |
| Open-market sales · 1,094 sh · avg $11.83 · $12,942 | |||||||
Loading xslF345X05/ownership.xml…